Difference between revisions of "Pracinostat (SB-939)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Kinase inhibitors" to "") |
||
| Line 9: | Line 9: | ||
[[Category:Orphan drug]] | [[Category:Orphan drug]] | ||
| − | + | ||
[[Category:HDAC inhibitors]] | [[Category:HDAC inhibitors]] | ||
[[Category:Acute myeloid leukemia medications]] | [[Category:Acute myeloid leukemia medications]] | ||
Revision as of 23:01, 28 February 2020
Mechanism of action
HDAC inhibitor
History of changes in FDA indication
- 2/27/2014: Granted FDA orphan drug status for treatment of acute myeloid leulemia.